Iris Unimi Prodmetadata only
Response to the letter Re: Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2- metastatic breast cancer in the US real-world setting
settore meds-09/a - oncologia medica
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 218364
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.